Two drugs that activate human defenses improve the prognosis for those with deadly skin cancer

The combination of a pair of drugs ‘awarded’ the Nobel Prize in Medicine reduces tumors in 28% of patients with aggressive melanoma

Related Keywords

Japan ,Madrid ,Spain ,California ,United States ,American ,Spanish ,Japanese ,Gregorio Mara ,Antoni Ribas ,James Allison ,Tasuku Honjo ,Los Angeles ,Spanish Society Of Medical Oncology ,European Medicines Agency ,International Agency For Research On Cancer ,Bristol Myers Squibb ,University Of California ,National Cancer Institute ,National Institutes Of Health ,Jonsson Comprehensive Cancer Center ,Tumor Immunology Program ,Nobel Prize ,Nature Medicine ,International Agency ,National Institutes ,Spanish Society ,